Identification and assessment of frailty in older patients with chronic myeloid leukemia and myelofibrosis, and indications for tyrosine kinase inhibitor treatment.

Annals of Hematology
Massimo BrecciaFrancesco Landi

Abstract

The incidence of cancer, including myeloproliferative neoplasms (MPNs), is projected to increase significantly due to the growing proportion of people aged > 65 years. These older individuals are a heterogeneous population in terms of fitness, comorbidity, and psychological reserve. Therefore, age per se does not always provide an accurate indication of condition in patients with cancer. Frailty has been proposed as an alternative measure of vulnerability that might better indicate which patients can tolerate standard cancer treatment and those who may benefit from treatment adjustment. A number of methods can be used to assess frailty in older patients with hematological malignancies, including the Cardiovascular Health Study Frailty Screening Measure, the FRAIL (Fatigue, Resistance, Ambulation, Illnesses, and Loss of weight) questionnaire, the Clinical Frailty Scale (CFS), and the Gérontopôle Frailty Screening Tool. In addition to physical frailty, comorbidity and quality of life should also be included in the assessment. Prior to the introduction of tyrosine kinase inhibitors (TKIs), age was considered a marker of poor prognosis in patients with MPNs. In contrast, data show that age is not necessarily a contraindication for ...Continue Reading

References

Feb 1, 1995·Journal of the American Geriatrics Society·P A ParmeleeM P Lawton
Mar 17, 2001·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·L P FriedUNKNOWN Cardiovascular Health Study Collaborative Research Group
Jan 30, 2004·The American Journal of Medicine·Mary E Tinetti, Terri Fried
Aug 9, 2005·Critical Reviews in Oncology/hematology·Martine ExtermannUNKNOWN Task Force on CGA of the International Society of Geriatric Oncology
Aug 11, 2005·JAMA : the Journal of the American Medical Association·Cynthia M BoydAlbert W Wu
Sep 1, 2005·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Kenneth RockwoodArnold Mitnitski
Nov 8, 2006·Journal of the American Geriatrics Society·Jama L PurserKaren P Alexander
Dec 20, 2008·Journal of the American Geriatrics Society·Marc D RothmanThomas M Gill
May 1, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Benjamin D SmithThomas A Buchholz
Jun 2, 2009·Cancer Treatment Reviews·Antonella BrunelloMartine Extermann
Nov 28, 2009·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Ruth E HubbardKenneth Rockwood
Dec 5, 2009·Best Practice & Research. Clinical Haematology·Maren Rohrbacher, Joerg Hasford
Mar 24, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrea LucianiPaolo Foa
Jun 8, 2010·The New England Journal of Medicine·Giuseppe SaglioUNKNOWN ENESTnd Investigators
Sep 11, 2010·BMJ : British Medical Journal·Rachel CooperUNKNOWN FALCon and HALCyon Study Teams
Dec 15, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Naseema GangatAyalew Tefferi
Jan 6, 2011·JAMA : the Journal of the American Medical Association·Stephanie StudenskiJack Guralnik
Jan 1, 2010·Mediterranean Journal of Hematology and Infectious Diseases·Lodovico Balducci
Jan 28, 2012·Critical Reviews in Oncology/hematology·Massimo BrecciaGiuliana Alimena
Mar 2, 2012·The New England Journal of Medicine·Claire HarrisonGiovanni Barosi
Mar 2, 2012·The New England Journal of Medicine·Srdan VerstovsekHagop M Kantarjian
Apr 19, 2012·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Leocadio Rodríguez-MañasUNKNOWN FOD-CC group (Appendix 1)
Jul 18, 2012·Archives of Internal Medicine·Michelle C OddenKenneth E Covinsky
Jul 28, 2012·The Journal of Nutrition, Health & Aging·J E MorleyD K Miller
Oct 17, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robyn M EmanuelRuben A Mesa
Oct 19, 2012·The Journal of Nutrition, Health & Aging·J SubraUNKNOWN Platform Team
Jun 15, 2013·Journal of the American Medical Directors Association·John E MorleyJeremy Walston
Aug 15, 2013·Current Cancer Drug Targets·Domenico RussoFederica Cattina
Sep 13, 2013·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Fabio EfficaceFranco Mandelli
Jun 25, 2014·Mediterranean Journal of Hematology and Infectious Diseases·Lodovico Balducci, Dawn Dolan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
Xiang-Long LiTing Liu
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Kristin M PhillipsPaul B Jacobsen
Expert Opinion on Pharmacotherapy
Maria Florencia TanakaElias Jabbour
© 2022 Meta ULC. All rights reserved